In a recent study, it was suggested that serum canine pancreatic lipase immunoreactivity (cPLI) which is the most commonly used marker for pancreatitis confirmation, together with CRP could be used as objective biomarkers for clinical improvement in hospitalized dogs (8). This evidence concerns the gene CRP and pancreatitis.